Loading…

Central 5-Ht Receptor Hypersensitivity in Migraine Without Aura

Serotonin has long been implicated as a key neurotransmitter in migraine. There is a dearth of research specifically examining 5-HT1A receptor sensitivity in migraine despite the importance of this receptor in regulating central serotonergic tone. In this study we examined the hypothesis that migrai...

Full description

Saved in:
Bibliographic Details
Published in:Cephalalgia 2003-02, Vol.23 (1), p.29-34
Main Authors: Cassidy, EM, Tomkins, E, Dinan, T, Hardiman, O, O'Keane, V
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4111-ae2f0569daadc37475ce2360368130d5d6b1a10d9f39da23e04e96bb657937b43
cites cdi_FETCH-LOGICAL-c4111-ae2f0569daadc37475ce2360368130d5d6b1a10d9f39da23e04e96bb657937b43
container_end_page 34
container_issue 1
container_start_page 29
container_title Cephalalgia
container_volume 23
creator Cassidy, EM
Tomkins, E
Dinan, T
Hardiman, O
O'Keane, V
description Serotonin has long been implicated as a key neurotransmitter in migraine. There is a dearth of research specifically examining 5-HT1A receptor sensitivity in migraine despite the importance of this receptor in regulating central serotonergic tone. In this study we examined the hypothesis that migraine without aura is associated with hypersensitivity of central 5-HT1A receptors, using a 5-HT1A neuroendocrine challenge drug and comparing serum prolactin responses between a test group with migraine and a matched group of healthy controls. Twelve female subjects fulfilling International Headache Society (IHS) criteria for migraine without aura were evaluated. Following an overnight fast, subjects presented for testing at 9am. An intravenous canula was inserted and serum prolactin was assessed at baseline and every 30 min for 3 h following a single dose of 30 mg oral buspirone, a 5-HT1A-receptor agonist. Subjects were assessed during the first 5 days of the menstrual cycle. No subjects were taking psychotropic medication or migraine prophylactic treatment. Patients with current or previous psychiatric disorder, daily headache or analgesic overuse were excluded. 16 healthy female volunteers matched for age and menstrual status were also evaluated and served as controls. There was no difference in baseline prolactin between groups. There was a significant rise in prolactin following buspirone in both groups. Subjects with migraine had a significantly increased prolactin response to buspirone (delta max) compared to controls (P < 0.001). This study supports the hypothesis that migraine without aura is associated with a relative hypersensitivity of central 5-HT1A receptors. This is of relevance given the role of the 5-HT1A receptor in controlling raphe 5-HT tone and in the possible association between migraine and anxiety and depression.
doi_str_mv 10.1046/j.1468-2982.2003.00441.x
format article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_72979003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1046_j.1468-2982.2003.00441.x</sage_id><sourcerecordid>72979003</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4111-ae2f0569daadc37475ce2360368130d5d6b1a10d9f39da23e04e96bb657937b43</originalsourceid><addsrcrecordid>eNqNkE1Lw0AQhhdRbK3-BcnJW-LsRzbNQaSUaoWKIorHZZNM65Y0qbuJNv_erS161NMMzPPODA8hAYWIgpCXy4gKOQxZOmQRA-ARgBA02hyQ_s_gkPSBcx5SYKJHTpxbAkAsQR6THmUxF3GS9Mn1GKvG6jKIw2kTPGGO66a2wbRbo3VYOdOYD9N0gamCe7Ow2lQYvJrmrW6bYNRafUqO5rp0eLavA_JyM3keT8PZw-3deDQLc0EpDTWyuT-eFloXOU9EEufIuAQuh5RDERcyo5pCkc65ZxhHEJjKLJNxkvIkE3xALnZ717Z-b9E1amVcjmWpK6xbpxKWJqk34cHhDsxt7ZzFuVpbs9K2UxTUVp5aqq0jtXWktvLUtzy18dHz_Y02W2HxG9zb8sDVDvg0JXb_XqzGk8ep73w-3uWdXqBa1q2tvLO_H_sCfyiMPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72979003</pqid></control><display><type>article</type><title>Central 5-Ht Receptor Hypersensitivity in Migraine Without Aura</title><source>SAGE Open Access</source><creator>Cassidy, EM ; Tomkins, E ; Dinan, T ; Hardiman, O ; O'Keane, V</creator><creatorcontrib>Cassidy, EM ; Tomkins, E ; Dinan, T ; Hardiman, O ; O'Keane, V</creatorcontrib><description>Serotonin has long been implicated as a key neurotransmitter in migraine. There is a dearth of research specifically examining 5-HT1A receptor sensitivity in migraine despite the importance of this receptor in regulating central serotonergic tone. In this study we examined the hypothesis that migraine without aura is associated with hypersensitivity of central 5-HT1A receptors, using a 5-HT1A neuroendocrine challenge drug and comparing serum prolactin responses between a test group with migraine and a matched group of healthy controls. Twelve female subjects fulfilling International Headache Society (IHS) criteria for migraine without aura were evaluated. Following an overnight fast, subjects presented for testing at 9am. An intravenous canula was inserted and serum prolactin was assessed at baseline and every 30 min for 3 h following a single dose of 30 mg oral buspirone, a 5-HT1A-receptor agonist. Subjects were assessed during the first 5 days of the menstrual cycle. No subjects were taking psychotropic medication or migraine prophylactic treatment. Patients with current or previous psychiatric disorder, daily headache or analgesic overuse were excluded. 16 healthy female volunteers matched for age and menstrual status were also evaluated and served as controls. There was no difference in baseline prolactin between groups. There was a significant rise in prolactin following buspirone in both groups. Subjects with migraine had a significantly increased prolactin response to buspirone (delta max) compared to controls (P &lt; 0.001). This study supports the hypothesis that migraine without aura is associated with a relative hypersensitivity of central 5-HT1A receptors. This is of relevance given the role of the 5-HT1A receptor in controlling raphe 5-HT tone and in the possible association between migraine and anxiety and depression.</description><identifier>ISSN: 0333-1024</identifier><identifier>EISSN: 1468-2982</identifier><identifier>DOI: 10.1046/j.1468-2982.2003.00441.x</identifier><identifier>PMID: 12534577</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>5‐HT1A ; Administration, Oral ; Adult ; Buspirone ; Female ; Humans ; Middle Aged ; Migraine ; Migraine without Aura - diagnosis ; Migraine without Aura - physiopathology ; prolactin ; Prolactin - blood ; Receptors, Serotonin - physiology ; Receptors, Serotonin, 5-HT1 ; Reference Values ; serotonin ; Serotonin - physiology ; Serotonin Receptor Agonists ; stress</subject><ispartof>Cephalalgia, 2003-02, Vol.23 (1), p.29-34</ispartof><rights>2003 International Headache Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4111-ae2f0569daadc37475ce2360368130d5d6b1a10d9f39da23e04e96bb657937b43</citedby><cites>FETCH-LOGICAL-c4111-ae2f0569daadc37475ce2360368130d5d6b1a10d9f39da23e04e96bb657937b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1046/j.1468-2982.2003.00441.x$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1046/j.1468-2982.2003.00441.x$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21966,27853,27924,27925,44945,45333</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1046/j.1468-2982.2003.00441.x?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12534577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cassidy, EM</creatorcontrib><creatorcontrib>Tomkins, E</creatorcontrib><creatorcontrib>Dinan, T</creatorcontrib><creatorcontrib>Hardiman, O</creatorcontrib><creatorcontrib>O'Keane, V</creatorcontrib><title>Central 5-Ht Receptor Hypersensitivity in Migraine Without Aura</title><title>Cephalalgia</title><addtitle>Cephalalgia</addtitle><description>Serotonin has long been implicated as a key neurotransmitter in migraine. There is a dearth of research specifically examining 5-HT1A receptor sensitivity in migraine despite the importance of this receptor in regulating central serotonergic tone. In this study we examined the hypothesis that migraine without aura is associated with hypersensitivity of central 5-HT1A receptors, using a 5-HT1A neuroendocrine challenge drug and comparing serum prolactin responses between a test group with migraine and a matched group of healthy controls. Twelve female subjects fulfilling International Headache Society (IHS) criteria for migraine without aura were evaluated. Following an overnight fast, subjects presented for testing at 9am. An intravenous canula was inserted and serum prolactin was assessed at baseline and every 30 min for 3 h following a single dose of 30 mg oral buspirone, a 5-HT1A-receptor agonist. Subjects were assessed during the first 5 days of the menstrual cycle. No subjects were taking psychotropic medication or migraine prophylactic treatment. Patients with current or previous psychiatric disorder, daily headache or analgesic overuse were excluded. 16 healthy female volunteers matched for age and menstrual status were also evaluated and served as controls. There was no difference in baseline prolactin between groups. There was a significant rise in prolactin following buspirone in both groups. Subjects with migraine had a significantly increased prolactin response to buspirone (delta max) compared to controls (P &lt; 0.001). This study supports the hypothesis that migraine without aura is associated with a relative hypersensitivity of central 5-HT1A receptors. This is of relevance given the role of the 5-HT1A receptor in controlling raphe 5-HT tone and in the possible association between migraine and anxiety and depression.</description><subject>5‐HT1A</subject><subject>Administration, Oral</subject><subject>Adult</subject><subject>Buspirone</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Migraine</subject><subject>Migraine without Aura - diagnosis</subject><subject>Migraine without Aura - physiopathology</subject><subject>prolactin</subject><subject>Prolactin - blood</subject><subject>Receptors, Serotonin - physiology</subject><subject>Receptors, Serotonin, 5-HT1</subject><subject>Reference Values</subject><subject>serotonin</subject><subject>Serotonin - physiology</subject><subject>Serotonin Receptor Agonists</subject><subject>stress</subject><issn>0333-1024</issn><issn>1468-2982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNkE1Lw0AQhhdRbK3-BcnJW-LsRzbNQaSUaoWKIorHZZNM65Y0qbuJNv_erS161NMMzPPODA8hAYWIgpCXy4gKOQxZOmQRA-ARgBA02hyQ_s_gkPSBcx5SYKJHTpxbAkAsQR6THmUxF3GS9Mn1GKvG6jKIw2kTPGGO66a2wbRbo3VYOdOYD9N0gamCe7Ow2lQYvJrmrW6bYNRafUqO5rp0eLavA_JyM3keT8PZw-3deDQLc0EpDTWyuT-eFloXOU9EEufIuAQuh5RDERcyo5pCkc65ZxhHEJjKLJNxkvIkE3xALnZ717Z-b9E1amVcjmWpK6xbpxKWJqk34cHhDsxt7ZzFuVpbs9K2UxTUVp5aqq0jtXWktvLUtzy18dHz_Y02W2HxG9zb8sDVDvg0JXb_XqzGk8ep73w-3uWdXqBa1q2tvLO_H_sCfyiMPQ</recordid><startdate>200302</startdate><enddate>200302</enddate><creator>Cassidy, EM</creator><creator>Tomkins, E</creator><creator>Dinan, T</creator><creator>Hardiman, O</creator><creator>O'Keane, V</creator><general>SAGE Publications</general><general>Blackwell Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200302</creationdate><title>Central 5-Ht Receptor Hypersensitivity in Migraine Without Aura</title><author>Cassidy, EM ; Tomkins, E ; Dinan, T ; Hardiman, O ; O'Keane, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4111-ae2f0569daadc37475ce2360368130d5d6b1a10d9f39da23e04e96bb657937b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>5‐HT1A</topic><topic>Administration, Oral</topic><topic>Adult</topic><topic>Buspirone</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Migraine</topic><topic>Migraine without Aura - diagnosis</topic><topic>Migraine without Aura - physiopathology</topic><topic>prolactin</topic><topic>Prolactin - blood</topic><topic>Receptors, Serotonin - physiology</topic><topic>Receptors, Serotonin, 5-HT1</topic><topic>Reference Values</topic><topic>serotonin</topic><topic>Serotonin - physiology</topic><topic>Serotonin Receptor Agonists</topic><topic>stress</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cassidy, EM</creatorcontrib><creatorcontrib>Tomkins, E</creatorcontrib><creatorcontrib>Dinan, T</creatorcontrib><creatorcontrib>Hardiman, O</creatorcontrib><creatorcontrib>O'Keane, V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cephalalgia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Cassidy, EM</au><au>Tomkins, E</au><au>Dinan, T</au><au>Hardiman, O</au><au>O'Keane, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Central 5-Ht Receptor Hypersensitivity in Migraine Without Aura</atitle><jtitle>Cephalalgia</jtitle><addtitle>Cephalalgia</addtitle><date>2003-02</date><risdate>2003</risdate><volume>23</volume><issue>1</issue><spage>29</spage><epage>34</epage><pages>29-34</pages><issn>0333-1024</issn><eissn>1468-2982</eissn><abstract>Serotonin has long been implicated as a key neurotransmitter in migraine. There is a dearth of research specifically examining 5-HT1A receptor sensitivity in migraine despite the importance of this receptor in regulating central serotonergic tone. In this study we examined the hypothesis that migraine without aura is associated with hypersensitivity of central 5-HT1A receptors, using a 5-HT1A neuroendocrine challenge drug and comparing serum prolactin responses between a test group with migraine and a matched group of healthy controls. Twelve female subjects fulfilling International Headache Society (IHS) criteria for migraine without aura were evaluated. Following an overnight fast, subjects presented for testing at 9am. An intravenous canula was inserted and serum prolactin was assessed at baseline and every 30 min for 3 h following a single dose of 30 mg oral buspirone, a 5-HT1A-receptor agonist. Subjects were assessed during the first 5 days of the menstrual cycle. No subjects were taking psychotropic medication or migraine prophylactic treatment. Patients with current or previous psychiatric disorder, daily headache or analgesic overuse were excluded. 16 healthy female volunteers matched for age and menstrual status were also evaluated and served as controls. There was no difference in baseline prolactin between groups. There was a significant rise in prolactin following buspirone in both groups. Subjects with migraine had a significantly increased prolactin response to buspirone (delta max) compared to controls (P &lt; 0.001). This study supports the hypothesis that migraine without aura is associated with a relative hypersensitivity of central 5-HT1A receptors. This is of relevance given the role of the 5-HT1A receptor in controlling raphe 5-HT tone and in the possible association between migraine and anxiety and depression.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>12534577</pmid><doi>10.1046/j.1468-2982.2003.00441.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0333-1024
ispartof Cephalalgia, 2003-02, Vol.23 (1), p.29-34
issn 0333-1024
1468-2982
language eng
recordid cdi_proquest_miscellaneous_72979003
source SAGE Open Access
subjects 5‐HT1A
Administration, Oral
Adult
Buspirone
Female
Humans
Middle Aged
Migraine
Migraine without Aura - diagnosis
Migraine without Aura - physiopathology
prolactin
Prolactin - blood
Receptors, Serotonin - physiology
Receptors, Serotonin, 5-HT1
Reference Values
serotonin
Serotonin - physiology
Serotonin Receptor Agonists
stress
title Central 5-Ht Receptor Hypersensitivity in Migraine Without Aura
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A25%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Central%205-Ht%20Receptor%20Hypersensitivity%20in%20Migraine%20Without%20Aura&rft.jtitle=Cephalalgia&rft.au=Cassidy,%20EM&rft.date=2003-02&rft.volume=23&rft.issue=1&rft.spage=29&rft.epage=34&rft.pages=29-34&rft.issn=0333-1024&rft.eissn=1468-2982&rft_id=info:doi/10.1046/j.1468-2982.2003.00441.x&rft_dat=%3Cproquest_AFRWT%3E72979003%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4111-ae2f0569daadc37475ce2360368130d5d6b1a10d9f39da23e04e96bb657937b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72979003&rft_id=info:pmid/12534577&rft_sage_id=10.1046_j.1468-2982.2003.00441.x&rfr_iscdi=true